Treatment of Chronic Active Antibody Mediated Rejection With Tocilizumab — Stella

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

About Browse conditions ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

Treatment of Chronic Active Antibody Mediated Rejection With Tocilizumab — Stella

Home/Kidney Transplant Rejection/

View on ClinicalTrials.gov

Recruiting

Back to Kidney Transplant Rejection trials

Not a traditional drug trial — this study doesn't follow the standard phase structure.

Trial locations(1 site)

Iran

Nooshin Dalili, Tehran

Key details

Sponsor

Shahid Beheshti University of Medical Sciences

Enrollment target

~50 participants

Started

January 2025

Primary completion

January 2027

Age range

18 Years and older

Last updated February 2026

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Stella acts as an intermediary. Researcher contact info is never exposed.

Follow this trial

Get notified in plain English when this trial's status changes. No account required.